Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Bill overview
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Reference notes
HB 3717 sources, status methodology and verification
Sources
- HB 3717 official legislative recordPrimary bill-status record.
- Current official bill textOfficial bill text or printing.
Methodology
KeepTXRed treats the official legislative record and latest official action as the factual status layer for HB 3717. Status labels are normalized for browsing, while the legislative timeline and documents preserve official action text and source links. Any KeepTXRed explanation below is editorial context and remains separate from the official record.
Last verified
Legislative record synchronized September 4, 2026 at 8:55 PM UTC; latest recorded official action May 12, 2025.
Bill → law → agency context
This relationship layer distinguishes what the normalized official record can prove from what it cannot. Enactment and effective dates come from the bill record. Agency names below are shown only when an official fiscal document supplies a verified agency reference; being cited in a fiscal note does not by itself prove that the agency administers the resulting law.
Official fiscal-note agency context
No verified agency references are available from the latest parsed official fiscal material. KeepTXRed does not infer an administering agency from the bill topic or title.
Current status
In committee
Laid on the table subject to call
Latest official action
Laid on the table subject to call
May 12, 2025 · house
Who this bill may affect
A verified audience or subject classification has not been attached to this bill yet.
Use the bill overview and official documents to determine whether the proposal may apply to you, your business, or a public agency.
Sponsors
coauthor
Committee history
- Public Health
Out of committee
Legislative timeline
Laid on the table subject to call
house · latest_action
Official recordCompanion considered in lieu of
house
Official recordPostponed
house
Official recordLaid out as postponed business
house
Official recordPostponed
house
Official recordLaid out as postponed business
house
Official recordPostponed
house
Official recordLaid out as postponed business
house
Official recordPostponed
house
Official recordRead 2nd time
house
Official recordPlaced on General State Calendar
house
Official recordConsidered in Calendars
house
Official recordCommittee report sent to Calendars
house
Official recordCommittee report distributed
house
Official recordComte report filed with Committee Coordinator
house
Official recordReported favorably w/o amendment(s)
house
Official recordConsidered in public hearing
house
Official recordLeft pending in committee
house
Official recordTestimony taken/registration(s) recorded in committee
house
Official recordConsidered in public hearing
house
Official recordScheduled for public hearing on . . .
house
Official recordReferred to Public Health
house
Official recordRead first time
house
Official recordFiled
house
Official record
Official bill text
Read source text published by the Texas Legislature. KeepTXRed fetches it only when you request it, converts the official HTML to inert text for display, and does not rewrite it with AI.
Related articles
KeepTXRed has not linked a related article to this bill yet. The legislative record above remains available independently of news coverage.
Related content
Ranked by official relationships such as sponsorship, committee referral, district, election, session, and direct news coverage.
Representative: angelia orr
author
Representative: cody harris
author
Representative: dade phelan
author
Representative: gary vandeaver
author
Representative: jeff leach
author
District: texas house district 1
sponsor district
District: texas house district 13
sponsor district
District: texas house district 21
sponsor district
District: texas house district 67
sponsor district
District: texas house district 8
sponsor district